Free Trial

Mind Medicine (MindMed) (MNMD) Competitors

Mind Medicine (MindMed) logo
$8.88 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$8.84 -0.04 (-0.51%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MNMD vs. TWST, DNLI, KNSA, AGIO, RXRX, CGON, VCEL, BEAM, BLTE, and IDYA

Should you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Twist Bioscience (TWST), Denali Therapeutics (DNLI), Kiniksa Pharmaceuticals International (KNSA), Agios Pharmaceuticals (AGIO), Recursion Pharmaceuticals (RXRX), CG Oncology (CGON), Vericel (VCEL), Beam Therapeutics (BEAM), Belite Bio (BLTE), and IDEAYA Biosciences (IDYA). These companies are all part of the "pharmaceutical products" industry.

Mind Medicine (MindMed) vs. Its Competitors

Twist Bioscience (NASDAQ:TWST) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Twist Bioscience has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500.

Mind Medicine (MindMed) has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Twist Bioscience$312.97M6.73-$208.73M-$3.25-10.82
Mind Medicine (MindMed)N/AN/A-$108.68M-$1.29-6.88

27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. 3.0% of Twist Bioscience shares are owned by insiders. Comparatively, 2.5% of Mind Medicine (MindMed) shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Mind Medicine (MindMed) has a net margin of 0.00% compared to Twist Bioscience's net margin of -54.98%. Twist Bioscience's return on equity of -33.48% beat Mind Medicine (MindMed)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Twist Bioscience-54.98% -33.48% -25.34%
Mind Medicine (MindMed) N/A -40.33%-32.13%

Twist Bioscience currently has a consensus price target of $50.40, indicating a potential upside of 43.30%. Mind Medicine (MindMed) has a consensus price target of $25.50, indicating a potential upside of 187.16%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Twist Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Twist Bioscience
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Mind Medicine (MindMed)
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
3 Strong Buy rating(s)
3.27

In the previous week, Twist Bioscience had 3 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 5 mentions for Twist Bioscience and 2 mentions for Mind Medicine (MindMed). Mind Medicine (MindMed)'s average media sentiment score of 1.26 beat Twist Bioscience's score of 0.68 indicating that Mind Medicine (MindMed) is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Twist Bioscience
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Mind Medicine (MindMed)
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mind Medicine (MindMed) beats Twist Bioscience on 9 of the 14 factors compared between the two stocks.

Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MNMD vs. The Competition

MetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ Exchange
Market Cap$670.91M$2.91B$5.52B$9.41B
Dividend YieldN/A2.45%3.80%4.04%
P/E RatioN/A19.8828.0419.84
Price / SalesN/A305.11429.5399.59
Price / CashN/A43.1635.8457.94
Price / Book2.777.678.125.65
Net Income-$108.68M-$55.28M$3.25B$258.00M
7 Day Performance10.17%2.50%0.97%2.09%
1 Month Performance25.25%11.70%7.36%11.13%
1 Year Performance7.90%4.89%31.31%18.40%

Mind Medicine (MindMed) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MNMD
Mind Medicine (MindMed)
2.1255 of 5 stars
$8.88
flat
$25.50
+187.2%
+5.8%$670.91MN/A-6.8840Positive News
TWST
Twist Bioscience
4.227 of 5 stars
$35.59
-6.8%
$50.40
+41.6%
-36.2%$2.13B$312.97M-10.95990News Coverage
DNLI
Denali Therapeutics
4.537 of 5 stars
$14.25
-3.0%
$33.71
+136.6%
-36.9%$2.07B$330.53M-5.34430
KNSA
Kiniksa Pharmaceuticals International
3.3535 of 5 stars
$27.95
+0.3%
$38.80
+38.8%
+34.7%$2.04B$481.17M-111.80220Upcoming Earnings
Insider Trade
AGIO
Agios Pharmaceuticals
4.409 of 5 stars
$35.21
-2.4%
$58.60
+66.4%
-14.4%$2.04B$36.50M3.13390
RXRX
Recursion Pharmaceuticals
1.1261 of 5 stars
$4.93
-6.5%
$7.00
+42.0%
-33.9%$2.00B$58.84M-2.79400Gap Up
High Trading Volume
CGON
CG Oncology
2.531 of 5 stars
$26.25
-2.4%
$58.67
+123.5%
-25.5%$2.00B$662K-17.3861News Coverage
Analyst Forecast
VCEL
Vericel
3.6832 of 5 stars
$39.41
-5.6%
$61.14
+55.1%
-29.9%$1.98B$237.22M1,314.10300News Coverage
Positive News
BEAM
Beam Therapeutics
2.0658 of 5 stars
$19.18
-4.1%
$48.75
+154.2%
-24.1%$1.93B$63.52M-4.16510Gap Up
BLTE
Belite Bio
1.831 of 5 stars
$58.63
-1.4%
$96.67
+64.9%
+26.6%$1.87BN/A-43.1110
IDYA
IDEAYA Biosciences
3.5047 of 5 stars
$21.16
-4.3%
$53.42
+152.4%
-45.7%$1.85B$7M-5.8980Positive News

Related Companies and Tools


This page (NASDAQ:MNMD) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners